Cipher Pharmaceuticals, Inc. (CPH.TO)
13.65
0.00 (0.00%)
CAD |
TSX |
Oct 09, 16:00
Cipher Pharmaceuticals Market Cap : 346.91M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 346.91M |
| October 08, 2026 | 346.91M |
| October 07, 2026 | 347.17M |
| October 06, 2026 | 352.25M |
| October 05, 2026 | 348.19M |
| October 02, 2026 | 346.91M |
| October 01, 2026 | 346.91M |
| September 30, 2026 | 346.91M |
| September 29, 2026 | 347.93M |
| September 28, 2026 | 346.91M |
| September 25, 2026 | 353.01M |
| September 24, 2026 | 357.33M |
| September 23, 2026 | 362.67M |
| September 22, 2026 | 369.28M |
| September 21, 2026 | 366.48M |
| September 18, 2026 | 372.84M |
| September 17, 2026 | 377.67M |
| September 16, 2026 | 368.77M |
| September 15, 2026 | 370.04M |
| September 14, 2026 | 375.38M |
| September 11, 2026 | 363.43M |
| September 10, 2026 | 360.89M |
| September 09, 2026 | 361.91M |
| September 08, 2026 | 359.62M |
| September 04, 2026 | 364.45M |
| Date | Value |
|---|---|
| September 03, 2026 | 365.72M |
| September 02, 2026 | 369.53M |
| September 01, 2026 | 360.64M |
| August 31, 2026 | 347.68M |
| August 28, 2026 | 354.54M |
| August 27, 2026 | 359.88M |
| August 26, 2026 | 358.35M |
| August 25, 2026 | 359.88M |
| August 24, 2026 | 358.35M |
| August 21, 2026 | 358.35M |
| August 20, 2026 | 363.94M |
| August 19, 2026 | 364.96M |
| August 18, 2026 | 363.69M |
| August 17, 2026 | 363.69M |
| August 14, 2026 | 359.37M |
| August 13, 2026 | 355.56M |
| August 12, 2026 | 358.61M |
| August 11, 2026 | 456.20M |
| August 10, 2026 | 446.54M |
| August 07, 2026 | 446.03M |
| August 06, 2026 | 450.69M |
| August 05, 2026 | 429.62M |
| August 04, 2026 | 433.42M |
| July 31, 2026 | 427.33M |
| July 30, 2026 | 417.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 127.89M |
| Bausch Health Cos., Inc. | 3.231B |
| BioSyent, Inc. | 194.49M |
| Revive Therapeutics Ltd. | 10.89M |
| Knight Therapeutics, Inc. | 1.064B |
Market Cap Related Metrics
| PE Ratio | 8.801 |
| PS Ratio | 5.139 |
| PEG Ratio | 0.0634 |
| Price to Book Value | 1.782 |
| Price to Free Cash Flow | 9.751 |
| Price | 13.65 |
| Earnings Yield | 11.36% |
| PEGY Ratio | 0.0634 |
| Operating PE Ratio | 13.26 |
| Normalized PE Ratio | 8.800 |